黄芪和三七的四种有效成分配伍对脑缺血再灌注后小鼠脑组织氧化应激的影响
Influence of four active components combination between Astragalus and Panax notoginseng on oxidative stress after cerebral ischemic-referfusion in mice
目的:探讨黄芪主要有效成分黄芪甲苷和三七的主要有效成分人参皂苷Rg1、人参皂苷Rb1和三七皂苷R1配伍对小鼠脑缺血再灌注后脑组织氧化应激的影响。方法:采用C57BL/6小鼠,随机分为11组,每天给药,连3天,末次给药1小时后,结扎双侧颈总动脉造成脑缺血20 min,再灌注24 h,取脑组织制备组织匀浆,以生化分析方法测定脑匀浆液丙二醛(MDA)、还原型谷胱甘肽(GSH)、一氧化氮(NO)含量和超氧化物歧化酶(SOD)活性。结果:1、与假手术组比较,模型组脑组织MDA、NO含量显著升高(均P<0.01),总SOD活性和GSH含量显著降低(P<0.01或P<0.05)。和模型组比较,黄芪甲苷组MDA、NO含量降低(均P<0.01),总SOD活性和GSH水平无显著性变化(P>0.05);人参皂苷Rg1显著减少NO含量(P<0.01),对MDA、总SOD活性和GSH水平均无影响(P>0.05);人参皂苷Rb1和三七皂苷R1对MDA、NO、SOD、GSH均无显著性影响(P>0.05)。2、黄芪甲苷与三七的三个有效成分分别配伍(两种有效成分配伍)均能显著减少MDA和NO含量(P<0.01或P<0.05),且黄芪甲苷与人参皂苷Rb1、三七皂苷R1组合的效应大于人参皂苷Rb1单用组和三七皂苷R1单用组(P<0.01或P<0.05);而两种有效成分配伍对SOD和GSH均无影响(P>0.05)。3、四种有效成分配伍可显著减少MDA和NO含量,提高总SOD活性和GSH水平(均P<0.01),且与绝大部分药物单用组和两种有效成分配伍组比较,效应更为显著(P<0.01或P<0.05)。4、黄芪甲苷、两种及四种有效成分配伍均可降低脑组织MDA含量,而三七的三个有效成分单用对MDA含量无显著影响。黄芪甲苷、人参皂苷Rg1、两种及四种有效成分配伍均可降低脑组织NO含量。四种有效成分单用、两种有效成分配伍对SOD活性和GSH含量均无显著影响,而四种有效成分配伍可显著增加脑缺血再灌注后SOD活性和GSH含量。结论:黄芪甲苷(40 mg.kg-1)与人参皂苷Rg1(50 mg.kg-1)、人参皂苷Rb1(40 mg.kg-1)及三七皂苷R1(10 mg.kg-1)配伍后,能明显减少小鼠脑缺血再灌注后氧化应激损伤,促进对脑组织的保护作用。且降低MDA的作用主要来自于黄芪甲苷,降低NO的作用主要来自于黄芪甲苷和人参皂苷Rg1,升高SOD活性和GSH含量的作用主要来自四种有效成分的联合作用。
Objective: To investigate the influence of astragaloside Ⅳ (the effective component of Astragalus) combined with ginsenoside Rg1, ginsenoside Rb1, notoginsenoside R1 (the effective components of Panax notoginseng) on oxidative stress after cerebral ischemic-referfusion in mice. Method: C56BL/6 mice were randomly divided into eleven group, then, models of cerebral ischemia-reperfusion injury were prepared by bilateral common carotid artery ligation for 20 min followed by 24 h reperfusion after treated for 3 days. Brain tissue was taken to yield a 10% homogenate, to detect the contents of Malonaldehyde (MDA), Nitric Oxide (NO), Glutathione (GSH) and the activity of Superoxide Dismutase (SOD) in brain tissue after reperfusion. Result: 1. Compared with the sham group, the contents of MDA、NO significantly were increased (all P<0.01), SOD activity and GSH level were decreased in the model group (P<0.01 or P<0.05). Compared with the model group, astragaloside Ⅳ significantly inhibited the increase in MDA, NO (all P<0.01), was less influenced on SOD, GSH (P>0.05); ginsenoside Rg1 reduced obviously NO content, had no marked effects on MDA, SOD, GSH (P>0.05); No significant effects (P>0.05) were all found on MDA, NO, SOD, GSH in ginsenoside Rb1 and notoginsenoside R1. 2. Astragaloside Ⅳ combined respectively with the active components of Panax notoginseng (two active components combination) all reduced obviously the contents of MDA and NO (P<0.01or P<0.05), and, the effects in astragaloside Ⅳ+ginsenoside Rb1 and astragaloside Ⅳ+notoginsenoside R1 were better than those in ginsenoside Rb1, notoginsenoside R1 alone; however, two active components combination had all no effects on SOD activity and GSH level (P>0.05). 3. Four active components combination decreased significantly the contents of MDA and NO, increased significantly SOD activity and GSH level (all P<0.01), furthermore, the effects were more obvious than those in the single-drug and two active components combination (P<0.01 or P<0.05). 4. Astragaloside Ⅳ, two or four active components combination decreased MDA, which did not been find in the active components of Panax notoginseng alone. Astragaloside Ⅳ, ginsenoside Rg1, two or four active components combination could inhibit the produce of NO. Four active component alone, two active components combination had no marked effects on SOD and GSH, but which were increased obviously in four active components combination. Conclusion: Combination between Astragaloside Ⅳ (40 mg.kg-1), ginsenoside Rg1 (50 mg.kg-1), ginsenoside Rb1 (40 mg.kg-1) and notoginsenoside R1 (10 mg.kg-1) inhibited significantly the early oxidative stress injury after cerebral ischemia-reperfusion in mice, promoted the protective effect on brain tissue. And the effect on MDA was mainly Astragaloside Ⅳ, the effect on NO was mainly astragaloside Ⅳ and ginsenoside Rg1, the effects on SOD activity and GSH level were four active components combination.
邓常清、黄小平、曾嵘、唐映红、邱咏园、王蓓
中医学基础医学药学
黄芪甲苷人参皂苷Rg1人参皂苷Rb1三七皂苷R1脑缺血再灌注57BL/6小鼠氧化应激
stragaloside Ⅳginsenoside Rg1ginsenoside Rb1notoginsenoside R1cerebral ischemia-reperfusionC57BL/6 miceoxidative stress
邓常清,黄小平,曾嵘,唐映红,邱咏园,王蓓.黄芪和三七的四种有效成分配伍对脑缺血再灌注后小鼠脑组织氧化应激的影响[EB/OL].(2012-09-14)[2025-08-02].http://www.paper.edu.cn/releasepaper/content/201209-158.点此复制
评论